Made from attenuated strains that have been safely used for more than 60 years
Two dosage forms, dragee candy and oral liquid
Included in EPI program
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>This product is an oral polio vaccine (OPV) containing live attenuated strains of Type I and Type III poliomyelitis virus propagated in human diploid cells. It induces systemic immunity against paralytic disease. <strong>CAS No.</strong> is not applicable for the final formulation as it comprises biological components rather than a single chemical entity.</p>
<h3>Application</h3>
<ul>
<li>National immunization programs for eradication campaigns</li>
<li>Outbreak response in endemic or high-risk regions</li>
<li>Epidemiological surveillance for wild virus monitoring</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in severe immunodeficiency, pregnancy, or acute febrile illness. Requires strict cold chain storage at -20°C to maintain viral potency and prevent reversion risks.</p>